Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400243 · ClinicalTrials.gov registry record · Phase 4
Nicotine Patch for Marijuana Withdrawal
A Phase 4 study, sponsored by Southern Illinois University Carbondale.
- Completed
- Registry status
- Phase 4
- Development phase
- 127
- Enrollment target
NCT01400243 is a Phase 4 study that has completed, run by Southern Illinois University Carbondale. The registered enrollment target is 127 participants.
The verdict
NCT01400243, a Phase 4 study, has completed, sponsored by Southern Illinois University Carbondale.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 127 participants
- Enrollment target
Study Summary
The purpose of this 3-year trial is to test the efficacy of transdermal nicotine patch versus placebo patch on marijuana withdrawal symptoms in cannabis-dependent individuals, using a randomized, double-blind, and placebo-controlled design. This proposal is in response to RFA-DA-10-016(R01) Medications Development for Cannabis-Related Disorders. Consistent with the goals of this RFA, the overall goal of the proposed project is to assess the impact of transdermal nicotine patch (TNP) on marijuana (MJ) withdrawal (negative affect and craving motivated by negative affect) symptoms in MJ-dependent individuals.
Interventions
- DRUG Placebo Patch
- DRUG Nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2011-04 |
| Est. Completion | 2014-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01400243
The ClinicalTrials.gov registry entry for NCT01400243 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern Illinois University Carbondale, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT01400243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01400243 about?
NCT01400243 is a clinical study titled "Nicotine Patch for Marijuana Withdrawal". The purpose of this 3-year trial is to test the efficacy of transdermal nicotine patch versus placebo patch on marijuana withdrawal symptoms in cannabis-dependent individuals, using a randomized, double-blind, and placebo-controlled design. This proposal is in response to RFA-DA-10-016(R01) Medicati...
What is the current status of trial NCT01400243?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 127 participants. The study started on 2011-04. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01400243?
The interventions under investigation include: Placebo Patch (DRUG), Nicotine (DRUG).
Who is sponsoring clinical trial NCT01400243?
This trial is sponsored by Southern Illinois University Carbondale, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.